Associations between in vivo neuroimaging and postmortem brain cytokine markers in a rodent model of Wernicke's encephalopathy

Experimental Neurology

Volumn 261, Issue , 2014, Pages 109-119

  Zahr, Natalie M ^a,b   Alt, Carsten ^b,c   Mayer, Dirk ^a,d   Rohlfing, Torsten ^b   Manning Bog, Amy ^b   Luong, Richard ^a   Sullivan, Edith V ^a   Pfefferbaum, Adolf ^a,b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SRI INTERNATIONAL   (United States)

^c Palo Alto Institute for Research and Education   (United States)

^d UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Brain; Immunohistochemistry; Lactate; Liver; Magnetic resonance imaging; Magnetic resonance spectroscopy; MCP 1; Microglia; TDP; Thiamine

Indexed keywords

BIOLOGICAL MARKER; CHEMOKINE; CYTOKINE; GLUCOSE; LACTIC ACID; MONOCYTE CHEMOTACTIC PROTEIN 1; N ACETYLASPARTIC ACID; PYRITHIAMINE; SODIUM CHLORIDE; THIAMINE; ASPARTIC ACID; CREATINE; N-ACETYLASPARTATE;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOPSY; BRAIN LEVEL; BRAIN TISSUE; GLUCOSE TOLERANCE TEST; IN VIVO STUDY; MALE; NERVE DEGENERATION; NERVOUS SYSTEM INFLAMMATION; NEUROIMAGING; NEUROPATHOLOGY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; RAT; RODENT MODEL; THALAMUS; THIAMINE DEFICIENCY; WERNICKE ENCEPHALOPATHY; ANALOGS AND DERIVATIVES; ANALYSIS OF VARIANCE; ANIMAL; BRAIN; DISEASE MODEL; LIVER; METABOLISM; NEUROLOGIC EXAMINATION; PATHOLOGY; TIME; WISTAR RAT;

ANALYSIS OF VARIANCE; ANIMALS; ASPARTIC ACID; BRAIN; CREATINE; CYTOKINES; DISEASE MODELS, ANIMAL; LIVER; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; NEUROLOGIC EXAMINATION; RATS; RATS, WISTAR; THIAMINE; TIME FACTORS; WERNICKE ENCEPHALOPATHY;

EID: 84905268746     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2014.06.015     Document Type: Article

References (93)

1. Adalsteinsson E., Hurd R.E., Mayer D., Sailasuta N., Sullivan E.V., Pfefferbaum A. In vivo 2D J-resolved magnetic resonance spectroscopy of rat brain with a 3-T clinical human scanner. NeuroImage 2004, 22:381-386.
2. 1H-MRS quantification method to assess different tissue alterations in multiple sclerosis. IEEE Trans. Biomed. Eng. 2012, 59:2687-2694.
3. Beauchesne E., Desjardins P., Hazell A.S., Butterworth R.F. eNOS gene deletion restores blood-brain barrier integrity and attenuates neurodegeneration in the thiamine-deficient mouse brain. J. Neurochem. 2009, 111:452-459.
4. Becker H.C. Animal models of alcohol withdrawal. Alcohol Res. Health 2000, 24:105-113.
5. Berger J.R., Singhal D. The neurologic complications of bariatric surgery. Handb. Clin. Neurol. 2014, 120:587-594.
6. Biros M.H., Dimlich R.V., Barsan W.G. Postinsult treatment of ischemia-induced cerebral lactic acidosis in the rat. Ann. Emerg. Med. 1986, 15:397-404.
7. Blair P.V., Kobayashi R., Edwards H.M., Shay N.F., Baker D.H., Harris R.A. Dietary thiamin level influences levels of its diphosphate form and thiamin-dependent enzymic activities of rat liver. J. Nutr. 1999, 129:641-648.
8. Block M.L., Hong J.S. Microglia and inflammation-mediated neurodegeneration: multiple triggers with a common mechanism. Prog. Neurobiol. 2005, 76:77-98.
9. Brin M. Erythrocyte as a biopsy tissue for functional evaluation of thiamine adequacy. JAMA 1964, 187:762-766.
10. Butterworth R.F. Pathophysiology of alcoholic brain damage: synergistic effects of ethanol, thiamine deficiency and alcoholic liver disease. Metab. Brain Dis. 1995, 10:1-8.
11. Calingasan N.Y., Gibson G.E. Vascular endothelium is a site of free radical production and inflammation in areas of neuronal loss in thiamine-deficient brain. Ann. N. Y. Acad. Sci. 2000, 903:353-356.
12. Chang L., Munsaka S.M., Kraft-Terry S., Ernst T. Magnetic resonance spectroscopy to assess neuroinflammation and neuropathic pain. J. Neuroimmune Pharmacol. 2013, 8:576-593.
13. Chronik B., Alejski A., Rutt B.K. Design and fabrication of a three-axis multilayer gradient coil for magnetic resonance microscopy of mice. Magma 2000, 10:131-146.
14. Chronik B.A., Alejski A., Rutt B.K. Design and fabrication of a three-axis edge ROU head and neck gradient coil. Magn. Reson. Med. 2000, 44:955-963.
15. Ciccia R.M., Langlais P.J. An examination of the synergistic interaction of ethanol and thiamine deficiency in the development of neurological signs and long-term cognitive and memory impairments. Alcohol. Clin. Exp. Res. 2000, 24:622-634.
16. Collins G.H. Glial cell changes in the brain stem of thiamine-deficient rats. Am. J. Pathol. 1967, 50:791-814.
17. Committee Guide for the Care and Use of Laboratory Animals 2010, National Academies Press, Washington, D.C. 8th edition ed.
18. Danielsen E., Ross B.D. Magnetic Resonance Spectroscopy Diagnosis of Neurological Diseases 1999, (New York). 1st ed.
19. Dreher W., Leibfritz D. Detection of homonuclear decoupled in vivo proton NMR spectra using constant time chemical shift encoding: CT-PRESS. Magn. Reson. Imaging 1999, 17:141-150.
20. Dror V., Eliash S., Rehavi M., Assaf Y., Biton I.E., Fattal-Valevski A. Neurodegeneration in thiamine deficient rats-a longitudinal MRI study. Brain Res. 2010, 1308:176-184.
21. Fell G.S., Talwar D. Assessment of status. Curr. Opin. Clin. Nutr. Metab. Care 1998, 1:491-497.
22. Fernando M.S., O'Brien J.T., Perry R.H., English P., Forster G., McMeekin W., Slade J.Y., Golkhar A., Matthews F.E., Barber R., Kalaria R.N., Ince P.G., Neuropathology Group of, M.C. Comparison of the pathology of cerebral white matter with post-mortem magnetic resonance imaging (MRI) in the elderly brain. Neuropathol. Appl. Neurobiol. 2004, 30:385-395.
23. Graeber M.B., Li W., Rodriguez M.L. Role of microglia in CNS inflammation. FEBS Lett. 2011, 585:3798-3805.
24. Hakim A.M. The induction and reversibility of cerebral acidosis in thiamine deficiency. Ann. Neurol. 1984, 16:673-679.
25. Harezlak J., Buchthal S., Taylor M., Schifitto G., Zhong J., Daar E., Alger J., Singer E., Campbell T., Yiannoutsos C., Cohen R., Navia B., Consortium, H.I.V.N. Persistence of HIV-associated cognitive impairment, inflammation, and neuronal injury in era of highly active antiretroviral treatment. AIDS 2011, 25:625-633.
26. Harper C.G. Sudden, unexpected death and Wernicke's encephalopathy: a complication of prolonged intravenous feeding. Aust. NZ J. Med. 1980, 10:230-235.
27. Higuchi T., Fernandez E.J., Maudsley A.A., Weiner M.W. Mapping of cerebral metabolites in rats by 1H magnetic resonance spectroscopic imaging. Distribution of metabolites in normal brain and postmortem changes. NMR Biomed. 1993, 6:311-317.
28. Inglese M., Li B.S., Rusinek H., Babb J.S., Grossman R.I., Gonen O. Diffusely elevated cerebral choline and creatine in relapsing-remitting multiple sclerosis. Magn. Reson. Med. 2003, 50:190-195.
29. Jordan L.R., Zelaya F.O., Rose S.E., Bower A.J., Galloway G., Wholohan T., Nixon P.F. Changes in the hippocampus induced by glucose in thiamin deficient rats detected by MRI. Brain Res. 1998, 791:347-351.
30. Jung Y.C., Chanraud S., Sullivan E.V. Neuroimaging of Wernicke's encephalopathy and Korsakoff's syndrome. Neuropsychol. Rev. 2012, 22:170-180.
31. Karuppagounder S.S., Shi Q., Xu H., Gibson G.E. Changes in inflammatory processes associated with selective vulnerability following mild impairment of oxidative metabolism. Neurobiol. Dis. 2007, 26:353-362.
32. Ke Z.J., Gibson G.E. Selective response of various brain cell types during neurodegeneration induced by mild impairment of oxidative metabolism. Neurochem. Int. 2004, 45:361-369.
33. Ke Z.J., Calingasan N.Y., DeGiorgio L.A., Volpe B.T., Gibson G.E. CD40-CD40L interactions promote neuronal death in a model of neurodegeneration due to mild impairment of oxidative metabolism. Neurochem. Int. 2005, 47:204-215.
34. Kirov I.I., Patil V., Babb J.S., Rusinek H., Herbert J., Gonen O. MR spectroscopy indicates diffuse multiple sclerosis activity during remission. J. Neurol. Neurosurg. Psychiatry 2009, 80:1330-1336.
35. Langlais P.J., Zhang S.X. Cortical and subcortical white matter damage without Wernicke's encephalopathy after recovery from thiamine deficiency in the rat. Alcohol. Clin. Exp. Res. 1997, 21:434-443.
36. Lee H., Tarter J., Holbourn G.E., Price R.R., Weinstein D.D., Martin P.R. In vivo localized proton NMR spectroscopy of thiamine-deficient rat brain. Magn. Reson. Med. 1995, 34:313-318.
37. Lee D.C., Chu J., Satz W., Silbergleit R. Low plasma thiamine levels in elder patients admitted through the emergency department. Acad. Emerg. Med. 2000, 7:1156-1159.
38. Lee H., Holburn G.E., Price R.R. In vivo and in vitro proton NMR spectroscopic studies of thiamine-deficient rat brains. J. Magn. Reson. Imaging 2001, 13:163-166.
39. Liu M., Alimov A.P., Wang H., Frank J.A., Katz W., Xu M., Ke Z.J., Luo J. Thiamine deficiency induces anorexia by inhibiting hypothalamic AMPK. Neuroscience 2014, 267:102-113.
40. Mader I., Rauer S., Gall P., Klose U. (1)H MR spectroscopy of inflammation, infection and ischemia of the brain. Eur. J. Radiol. 2008, 67:250-257.
41. Mancinelli R., Ceccanti M., Guiducci M.S., Sasso G.F., Sebastiani G., Attilia M.L., Allen J.P. Simultaneous liquid chromatographic assessment of thiamine, thiamine monophosphate and thiamine diphosphate in human erythrocytes: a study on alcoholics. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 2003, 789:355-363.
42. Mascalchi M., Belli G., Guerrini L., Nistri M., Del Seppia I., Villari N. Proton MR spectroscopy of Wernicke encephalopathy. AJNR 2002, 23:1803-1806.
43. Mayer D., Spielman D.M. Detection of glutamate in the human brain at 3T using optimized constant time point resolved spectroscopy. Magn. Reson. Med. 2005, 54:439-442.
44. McLarnon J.G. Correlated inflammatory responses and neurodegeneration in peptide-injected animal models of Alzheimer's disease. Biomed. Res. Int. 2014, 2014:923670.
45. McRee R.C., Terry-Ferguson M., Langlais P.J., Chen Y., Nalwalk J.W., Blumenstock F.A., Hough L.B. Increased histamine release and granulocytes within the thalamus of a rat model of Wernicke's encephalopathy. Brain Res. 2000, 858:227-236.
46. Meng J.S., Okeda R. Neuropathological study of the role of mast cells and histamine-positive neurons in selective vulnerability of the thalamus and inferior colliculus in thiamine-deficient encephalopathy. Neuropathology 2003, 23:25-35.
47. Merola J.F., Ghoroghchian P.P., Samuels M.A., Levy B.D., Loscalzo J. Clinical problem-solving. At a loss. N. Engl. J. Med. 2012, 367:67-72.
48. Minami M., Satoh M. Chemokines and their receptors in the brain: pathophysiological roles in ischemic brain injury. Life Sci. 2003, 74:321-327.
49. Muessel M.J., Berman N.E., Klein R.M. Early and specific expression of monocyte chemoattractant protein-1 in the thalamus induced by cortical injury. Brain Res. 2000, 870:211-221.
50. 1)H-MRS of Wernicke's encephalopathy: report of a case with remarkable cerebellar lesions on MRI. Psychiatry Res. 2001, 108:49-55.
51. Najjar S., Pearlman D.M., Hirsch S., Friedman K., Strange J., Reidy J., Khoukaz M., Ferrell R.B., Devinsky O., Najjar A., Zagzag D. Brain biopsy findings link major depressive disorder to neuroinflammation, oxidative stress, and neurovascular dysfunction: a case report. Biol. Psychiatry 2014, 75:e23-e26.
52. 13C nuclear magnetic resonance spectroscopy. J. Neurosci. Res. 2005, 79:33-41.
53. Nixon P.F., Jordan L., Zimitat C., Rose S.E., Zelaya F. Choroid plexus dysfunction: the initial event in the pathogenesis of Wernicke's encephalopathy and ethanol intoxication. Alcohol. Clin. Exp. Res. 2008, 32:1513-1523.
54. Okada T., Sakamoto S., Nakamoto Y., Kohara N., Senda M. Reproducibility of magnetic resonance spectroscopy in correlation with signal-to-noise ratio. Psychiatry Res. 2007, 156:169-174.
55. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates 2005, Elsevier Academic Press, London.
56. Petito C.K., Kraig R.P., Pulsinelli W.A. Light and electron microscopic evaluation of hydrogen ion-induced brain necrosis. J. Cereb. Blood Flow Metab. 1987, 7:625-632.
57. Pfefferbaum A., Adalsteinsson E., Bell R.L., Sullivan E.V. Development and resolution of brain lesions caused by pyrithiamine- and dietary-induced thiamine deficiency and alcohol exposure in the alcohol-preferring rat: a longitudinal magnetic resonance imaging and spectroscopy study. Neuropsychopharmacology 2007, 32:1149-1177.
58. Pirko I., Johnson A.J. Neuroimaging of demyelination and remyelination models. Curr. Top. Microbiol. Immunol. 2008, 318:241-266.
59. Pitkin S.R., Savage L.M. Aging potentiates the acute and chronic neurological symptoms of pyrithiamine-induced thiamine deficiency in the rodent. Behav. Brain Res. 2001, 119:167-177.
60. Rigotti D.J., Gass A., Achtnichts L., Inglese M., Babb J.S., Naegelin Y., Hirsch J., Amann M., Kappos L., Gonen O. Multiple sclerosis severity scale and whole-brain N-acetylaspartate concentration for patients' assessment. Mult. Scler. 2012, 18:98-107.
61. Roberts A.J., Cole M., Koob G.F. Intra-amygdala muscimol decreases operant ethanol self-administration in dependent rats. Alcohol. Clin. Exp. Res. 1996, 20:1289-1298.
62. Robertson D.M., Wasan S.M., Skinner D.B. Ultrastructural features of early brain stem lesions of thiamine-deficient rats. Am. J. Pathol. 1968, 52:1081-1097.
63. Rose S.E., Nixon P.F., Zelaya F.O., Wholohan B.T., Zimitat C., Moxon L.N., Crozier S., Brereton I.M., Doddrell D.M. Application of high field localised in vivo 1H MRS to study biochemical changes in the thiamin deficient rat brain under glucose load. NMR Biomed. 1993, 6:324-328.
64. Rugilo C.A., Uribe Roca M.C., Zurru M.C., Capizzano A.A., Pontello G.A., Gatto E.M. Proton MR spectroscopy in Wernicke encephalopathy. AJNR 2003, 24:952-955.
65. Sanchez-Guajardo V., Barnum C.J., Tansey M.G., Romero-Ramos M. Neuroimmunological processes in Parkinson's disease and their relation to alpha-synuclein: microglia as the referee between neuronal processes and peripheral immunity. ASN Neuro. 2013, 5:113-139.
66. Schilling M., Strecker J.K., Ringelstein E.B., Kiefer R., Schabitz W.R. Turn-over of meningeal and perivascular macrophages in the brain of MCP-1-, CCR-2- or double knockout mice. Exp. Neurol. 2009, 219:583-585.
67. Schweinsburg B.C., Taylor M.J., Alhassoon O.M., Gonzalez R., Brown G.G., Ellis R.J., Letendre S., Videen J.S., McCutchan J.A., Patterson T.L., Grant I., Group H. Brain mitochondrial injury in human immunodeficiency virus-seropositive (HIV+) individuals taking nucleoside reverse transcriptase inhibitors. J. Neurovirol. 2005, 11:356-364.
68. Semple B.D., Kossmann T., Morganti-Kossmann M.C. Role of chemokines in CNS health and pathology: a focus on the CCL2/CCR2 and CXCL8/CXCR2 networks. J. Cereb. Blood Flow Metab. 2010, 30:459-473.
69. Siesjo B.K. Lactic acidosis in the brain: occurrence, triggering mechanisms and pathophysiological importance. CIBA Found. Symp. 1982, 87:77-100.
70. Sullivan T.J. Thiamine deficiency presenting as opisthotonus. J. Pediatr. 1970, 77:1092-1093.
71. Tellez I., Terry R.D. Fine structure of the early changes in the vestibular nuclei of the thiamine-deficient rat. Am. J. Pathol. 1968, 52:777-794.
72. Todd K.G., Butterworth R.F. Early microglial response in experimental thiamine deficiency: an immunohistochemical analysis. Glia 1999, 25:190-198.
73. Toews A.D., Barrett C., Morell P. Monocyte chemoattractant protein 1 is responsible for macrophage recruitment following injury to sciatic nerve. J. Neurosci. Res. 1998, 53:260-267.
74. Tourdias T., Hiba B., Raffard G., Biran M., Nishiguchi T., Aussudre J., Franconi J.M., Brochet B., Petry K.G., Dousset V. Adapted focal experimental autoimmune encephalomyelitis to allow MRI exploration of multiple sclerosis features. Exp. Neurol. 2011, 230:248-257.
75. Upthegrove R., Manzanares-Teson N., Barnes N.M. Cytokine function in medication-naive first episode psychosis: a systematic review and meta-analysis. Schizophr. Res. 2014, 155:101-108.
76. Valcour V., Chalermchai T., Sailasuta N., Marovich M., Lerdlum S., Suttichom D., Suwanwela N.C., Jagodzinski L., Michael N., Spudich S., van Griensven F., de Souza M., Kim J., Ananworanich J., Group R.S.S. Central nervous system viral invasion and inflammation during acute HIV infection. J. Infect. Dis. 2012, 206:275-282.
77. van der Toorn A., Verheul H.B., Berkelbach van der Sprenkel J.W., Tulleken C.A., Nicolay K. Changes in metabolites and tissue water status after focal ischemia in cat brain assessed with localized proton MR spectroscopy. Magn. Reson. Med. 1994, 32:685-691.
78. Vemuganti R., Kalluri H., Yi J.H., Bowen K.K., Hazell A.S. Gene expression changes in thalamus and inferior colliculus associated with inflammation, cellular stress, metabolism and structural damage in thiamine deficiency. Eur. J. Neurosci. 2006, 23:1172-1188.
79. Vetreno R.P., Ramos R.L., Anzalone S., Savage L.M. Brain and behavioral pathology in an animal model of Wernicke's encephalopathy and Wernicke-Korsakoff Syndrome. Brain Res. 2012, 1436:178-192.
80. Victor M., Adams R.D., Collins G.H. The Wernicke-Korsakoff Syndrome 1971, F.A. Davis Co, Philadelphia.
81. Victor M., Adams R.D., Collins G.H. The Wernicke-Korsakoff Syndrome and Related Neurologic Disorders Due to Alcoholism and Malnutrition (2nd edition) 1989, F.A. Davis Co, Philadelphia.
82. Wagner K.R., Ting P., Westfall M.V., Yamaguchi S., Bacher J.D., Myers R.E. Brain metabolic correlates of hypoxic-ischemic cerebral necrosis in mid-gestational sheep fetuses: significance of hypotension. J. Cereb. Blood Flow Metab. 1986, 6:425-434.
83. Wallis W.E., Willoughby E., Baker P. Coma in the Wernicke-Korsakoff syndrome. Lancet 1978, 2:400-401.
84. Warnock L.G., Prudhomme C.R., Wagner C. The determination of thiamin pyrophosphate in blood and other tissues, and its correlation with erythrocyte transketolase activity. J. Nutr. 1978, 108:421-427.
85. Watanabe I., Kanabe S. Early edematous lesion of pyrithiamine induced acute thiamine deficient encephalopathy in the mouse. J. Neuropathol. Exp. Neurol. 1978, 37:401-413.
86. Watson A.J., Walker J.F., Tomkin G.H., Finn M.M., Keogh J.A. Acute Wernickes encephalopathy precipitated by glucose loading. Ir. J. Med. Sci. 1981, 150:301-303.
87. Xu H., Zhang S.L., Tan G.W., Zhu H.W., Huang C.Q., Zhang F.F., Wang Z.X. Reactive gliosis and neuroinflammation in rats with communicating hydrocephalus. Neuroscience 2012, 218:317-325.
88. Yaksh T.L., Kohl R.L., Rudy T.A. Induction of tolerance and withdrawal in rats receiving morphine in the spinal subarachnoid space. Eur. J. Pharmacol. 1977, 42:275-284.
89. Yang G., Meng Y., Li W., Yong Y., Fan Z., Ding H., Wei Y., Luo J., Ke Z.J. Neuronal MCP-1 mediates microglia recruitment and neurodegeneration induced by the mild impairment of oxidative metabolism. Brain Pathol. 2011, 21:279-297.
90. Zahr N.M., Crawford E.L., Hsu O., Vinco S., Mayer D., Rohlfing T., Sullivan E.V., Pfefferbaum A. In vivo glutamate decline associated with kainic acid-induced status epilepticus. Brain Res. 2009, 1300:65-78.
91. Zahr N.M., Mayer D., Vinco S., Orduna J., Luong R., Sullivan E.V., Pfefferbaum A. In vivo evidence for alcohol-induced neurochemical changes in rat brain without protracted withdrawal, pronounced thiamine deficiency, or severe liver damage. Neuropsychopharmacology 2009, 34:1427-1442.
92. Zahr N.M., Mayer D., Rohlfing T., Orduna J., Luong R., Sullivan E.V., Pfefferbaum A. A mechanism of rapidly reversible cerebral ventricular enlargement independent of tissue atrophy. Neuropsychopharmacology 2013, 38:1121-1129.
93. Zhang S.X., Weilersbacher G.S., Henderson S.W., Corso T., Olney J.W., Langlais P.J. Excitotoxic cytopathology, progression, and reversibility of thiamine deficiency-induced diencephalic lesions. J. Neuropathol. Exp. Neurol. 1995, 54:255-267.